By Nilson Feliz, MD, Manuel Fernandez, MD, Lisa M. Sebastian, MD, Roberto L. Collazo-Maldonado, MD, FACP A 60-year old African American man was referred for evaluation of nephrotic syndrome. His past medical history was positive for HTN, DM, and Hepatitis C — successfully treated with ombitasvir/periteprevir/dasabuvir for three months. His hepatitis C viral load was … Continued

By Harold Szerlip, MD MS(ED), FACP, FCCP, FASN, FNKF, CCRP and Bernard V. Fischbach, MD, CCRP Chronic kidney disease (CKD) is a general term for diverse disorders affecting kidney structure and function with a variable clinical presentation. The Centers for Disease Control (CDC) estimates that more than 20 million adults, in the U.S., may have … Continued

By Harold Szerlip, MD MS(ED), FACP, FCCP, FASN, FNKF, CCRP Get ready for a significant change in the hypertension guideline. The SPRINT trial, which compared intensive treatment for hypertension (< 120 mm Hg systolic) to the present guidelines (< 140 mm Hg) was terminated early by the data safety monitoring committee because of a > … Continued

The Renal Disease Research Institute (RDRI) is a new research entity affiliated with Dallas Nephrology Associates. There is significant ethical oversight of this entity through RDRI’s Board of Managers and Scientific Review Committee. Currently, there are several potential clinical research trials in the pipeline. RDRI’s first active clinical trial is a device trial spearheaded by … Continued